96 related articles for article (PubMed ID: 16831476)
1. In vivo real-time vessel imaging and ex vivo 3D reconstruction of atherosclerotic plaque in apolipoprotein E-knockout mice using synchrotron radiation microscopy.
Kim JW; Seo HS; Hwu Y; Je JH; Kim A; Oh CW; Suh SY; Rha SW; Park CG; Oh DJ
Int J Cardiol; 2007 Jan; 114(2):166-71. PubMed ID: 16831476
[TBL] [Abstract][Full Text] [Related]
2. In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice.
Yasuda S; Ikuta K; Uwatoku T; Oi K; Abe K; Hyodo F; Yoshimitsu K; Sugimura K; Utsumi H; Katayama Y; Shimokawa H
J Vasc Res; 2008; 45(2):123-8. PubMed ID: 17940339
[TBL] [Abstract][Full Text] [Related]
3. Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia.
Trogan E; Fayad ZA; Itskovich VV; Aguinaldo JG; Mani V; Fallon JT; Chereshnev I; Fisher EA
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1714-9. PubMed ID: 15256400
[TBL] [Abstract][Full Text] [Related]
4. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/low-density lipoprotein(-/-) double knockout mice.
Langheinrich AC; Michniewicz A; Sedding DG; Walker G; Beighley PE; Rau WS; Bohle RM; Ritman EL
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):347-52. PubMed ID: 16293797
[TBL] [Abstract][Full Text] [Related]
5. High-resolution magnetic resonance imaging at 2 Tesla: potential for atherosclerotic lesions exploration in the apolipoprotein E knockout mouse.
Chaabane L; Soulas EC; Contard F; Salah A; Guerrier D; Briguet A; Douek P
Invest Radiol; 2003 Aug; 38(8):532-8. PubMed ID: 12874520
[TBL] [Abstract][Full Text] [Related]
6. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.
Deguchi JO; Aikawa M; Tung CH; Aikawa E; Kim DE; Ntziachristos V; Weissleder R; Libby P
Circulation; 2006 Jul; 114(1):55-62. PubMed ID: 16801460
[TBL] [Abstract][Full Text] [Related]
7. Remodelling of the zero-stress state and residual strains in apoE-deficient mouse aorta.
Gregersen H; Zhao J; Lu X; Zhou J; Falk E
Biorheology; 2007; 44(2):75-89. PubMed ID: 17538200
[TBL] [Abstract][Full Text] [Related]
8. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease.
Aikawa E; Nahrendorf M; Sosnovik D; Lok VM; Jaffer FA; Aikawa M; Weissleder R
Circulation; 2007 Jan; 115(3):377-86. PubMed ID: 17224478
[TBL] [Abstract][Full Text] [Related]
9. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo.
Aikawa E; Nahrendorf M; Figueiredo JL; Swirski FK; Shtatland T; Kohler RH; Jaffer FA; Aikawa M; Weissleder R
Circulation; 2007 Dec; 116(24):2841-50. PubMed ID: 18040026
[TBL] [Abstract][Full Text] [Related]
10. The long-term effect of angiotensin II type 1a receptor deficiency on hypercholesterolemia-induced atherosclerosis.
Eto H; Miyata M; Shirasawa T; Akasaki Y; Hamada N; Nagaki A; Orihara K; Biro S; Tei C
Hypertens Res; 2008 Aug; 31(8):1631-42. PubMed ID: 18971539
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
12. The role of complement in the adherence of microbubbles to dysfunctional arterial endothelium and atherosclerotic plaque.
Anderson DR; Tsutsui JM; Xie F; Radio SJ; Porter TR
Cardiovasc Res; 2007 Feb; 73(3):597-606. PubMed ID: 17196951
[TBL] [Abstract][Full Text] [Related]
13. Detection of vulnerable plaque in a murine model of atherosclerosis with optical coherence tomography.
Cilingiroglu M; Oh JH; Sugunan B; Kemp NJ; Kim J; Lee S; Zaatari HN; Escobedo D; Thomsen S; Milner TE; Feldman MD
Catheter Cardiovasc Interv; 2006 Jun; 67(6):915-23. PubMed ID: 16602128
[TBL] [Abstract][Full Text] [Related]
14. Mast cell degranulator compound 48-80 promotes atherosclerotic plaque in apolipoprotein E knockout mice with perivascular common carotid collar placement.
Tang YL; Yang YZ; Wang S; Huang T; Tang CK; Xu ZX; Sun YH
Chin Med J (Engl); 2009 Feb; 122(3):319-25. PubMed ID: 19236812
[TBL] [Abstract][Full Text] [Related]
15. Functional effects of eggs, naturally enriched with conjugated linoleic acid, on the blood lipid profile, development of atherosclerosis and composition of atherosclerotic plaque in apolipoprotein E and low-density lipoprotein receptor double-knockout mice (apoE/LDLR-/-).
Franczyk-Zarów M; Kostogrys RB; Szymczyk B; Jawień J; Gajda M; Cichocki T; Wojnar L; Chlopicki S; Pisulewski PM
Br J Nutr; 2008 Jan; 99(1):49-58. PubMed ID: 17678565
[TBL] [Abstract][Full Text] [Related]
16. Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Koga M; Kai H; Yasukawa H; Kato S; Yamamoto T; Kawai Y; Kusaba K; Seki Y; Kai M; Egashira K; Kataoka Y; Imaizumi T
Hypertens Res; 2007 Mar; 30(3):259-67. PubMed ID: 17510508
[TBL] [Abstract][Full Text] [Related]
17. Atherosclerosis and the protective role played by different proteins in apolipoprotein E-deficient mice.
Fabrizio Rodella L; Bonomini F; Rezzani R; Tengattini S; Hayek T; Aviram M; Keidar S; Coleman R; Bianchi R
Acta Histochem; 2007; 109(1):45-51. PubMed ID: 17046051
[TBL] [Abstract][Full Text] [Related]
18. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
[TBL] [Abstract][Full Text] [Related]
19. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
[TBL] [Abstract][Full Text] [Related]
20. Melagatran reduces advanced atherosclerotic lesion size and may promote plaque stability in apolipoprotein E-deficient mice.
Bea F; Kreuzer J; Preusch M; Schaab S; Isermann B; Rosenfeld ME; Katus H; Blessing E
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2787-92. PubMed ID: 16990551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
